139 related articles for article (PubMed ID: 15684489)
1. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
[TBL] [Abstract][Full Text] [Related]
2. Rate and extent of absorption of clonidine from a transdermal therapeutic system.
Toon S; Hopkins KJ; Aarons L; Rowland M
J Pharm Pharmacol; 1989 Jan; 41(1):17-21. PubMed ID: 2565958
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
Shaw JE
Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
[TBL] [Abstract][Full Text] [Related]
4. In vitro/in vivo functionality of Catapres-TTS.
Enscore DJ; Osborne JL; Shaw JE
Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):173-8. PubMed ID: 2657275
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.
Arndts D; Arndts K
Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294
[TBL] [Abstract][Full Text] [Related]
6. Patient acceptance of transdermal clonidine. A retrospective review of 25 patients.
Chen SW; Vidt DG
Cleve Clin J Med; 1989; 56(1):21-6. PubMed ID: 2731324
[TBL] [Abstract][Full Text] [Related]
7. Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients.
Broderick-Cantwell JJ
J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):95-8. PubMed ID: 9893422
[TBL] [Abstract][Full Text] [Related]
8. [Determination of clonidine in rabbit plasma by HPLC-MS].
Ke GM; Zhang EH; Wang L; Zhang Q; Du HG; Guo HY
Yao Xue Xue Bao; 2004 May; 39(5):367-9. PubMed ID: 15338881
[TBL] [Abstract][Full Text] [Related]
9. Transdermal clonidine application: long-term results in essential hypertension.
Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
[TBL] [Abstract][Full Text] [Related]
10. Skin pretreatment and the use of transdermal clonidine.
Ito MK; O'Connor DT
Am J Med; 1991 Jul; 91(1A):42S-49S. PubMed ID: 1831005
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antihypertensive effect of TTS clonidine by multiple 24-hour automatic blood pressure monitoring.
Mancia G; Parati G; Pomidossi G; Malaspina D; Colombo A; Camesasca C; Groppelli A; Casadei R; Zanchetti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S187-93. PubMed ID: 2455177
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period.
Segal IS; Jarvis DJ; Duncan SR; White PF; Maze M
Anesthesiology; 1991 Feb; 74(2):220-5. PubMed ID: 1990896
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence and adhesion evaluation of transdermal clonidine following a change in excipient supplier.
Ehrlich J; Beck B; Thiedmann R; Marzin K; MacGregor T
Int J Clin Pharmacol Ther; 2016 Oct; 54(10):816-24. PubMed ID: 27390050
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects.
Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
[TBL] [Abstract][Full Text] [Related]
16. Transdermal and oral clonidine.
Lilja M; Juustila H; Sarna S; Jounela AJ
Ann Med; 1991 Aug; 23(3):265-9. PubMed ID: 1930916
[TBL] [Abstract][Full Text] [Related]
17. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
Lewis GR
N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
[TBL] [Abstract][Full Text] [Related]
18. Transdermal clonidine compared with hydrochlorothiazide as monotherapy in elderly hypertensive males.
Schmidt GR; Schuna AA; Goodfriend TL
J Clin Pharmacol; 1989 Feb; 29(2):133-9. PubMed ID: 2715369
[TBL] [Abstract][Full Text] [Related]
19. Dose linearity of clonidine after transdermal application.
Wallenstein G; Gladigau V
Clin Auton Res; 1993 Dec; 3(6):369-72. PubMed ID: 8193523
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of clonidine.
Lowenthal DT; Matzek KM; MacGregor TR
Clin Pharmacokinet; 1988 May; 14(5):287-310. PubMed ID: 3293868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
